# Study EvAluating Genotypes While Using Lucentis 2

> **NCT01464723** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 66 (actual)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT01464723
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2011-12
- **Final completion:** 2013-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464723, "Study EvAluating Genotypes While Using Lucentis 2". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01464723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*